M. Sandmann

Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial

W. Brenner, R. Boellaard, W. Klapper, 2020, Hematological oncology.

Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin’s lymphoma

S. Seeber, M. Stuschke, N. Niederle, 2009, Journal of Cancer Research and Clinical Oncology.

Treatment of the bone marrow failure in Fanconi anemia patients with danazol.

D. Schindler, H. Hanenberg, W. Scheurlen, 2012, Blood cells, molecules & diseases.

Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participating in the PETAL Trial

W. Brenner, W. Klapper, C. Franzius, 2016 .